Signaturefd, LLC Ngm Biopharmaceuticals Inc Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$3.72 - $5.4 $19,102 - $27,729	5,135 Added 1625.0%	5,451 $22,000
Q4 2022 Jan 27, 2023	SELL	$3.41 - $12.93 $105 - $400	-31 Reduced 8.93%	316 $1,000
Q3 2022 Nov 08, 2022	BUY	$12.59 - $17.67 $2,593 - $3,640	206 Added 146.1%	347 $5,000
Q2 2022 Aug 10, 2022	BUY	$10.58 - $17.5 $730 - $1,207	69 Added 95.83%	141 $2,000
Q1 2022 May 02, 2022	BUY	$13.81 - $18.6 $994 - $1,339	72 New	72 $1,000
Q2 2021 Jul 26, 2021	SELL	$15.06 - $30.03 $361 - $720	-24 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$24.99 - $31.93 $599 - $766	24 New	24 $1,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.